shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen
Company profile
Ticker
SWAV
Exchange
Website
CEO
Douglas Godshall
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ShockWave Medical, Inc.
SEC CIK
Corporate docs
Subsidiaries
Neovasc Inc. • Neovasc Tiara Inc. • SWAV CR Sociedad de Responsabilidad Limitada • Shockwave Medical GmbH • Neovasc GmbH • Shockwave Medical India Private Limited • Shockwave Medical Ireland Limited • Shockwave Medical Italy S.R.L. • Shockwave Medical Portugal, Unipessoal Lda. • Genesis Shockwave Private Limited ...
IRS number
270494101
SWAV stock data
Latest filings (excl ownership)
PREM14A
Preliminary proxy related to merger
18 Apr 24
8-K
Departure of Directors or Certain Officers
9 Apr 24
DFAN14A
Additional proxy materials by non-management
5 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
8-K
Johnson & Johnson to Acquire Shockwave Medical
5 Apr 24
8-K
Changes in Registrant's Certifying Accountant
1 Mar 24
S-8
Registration of securities for employees
26 Feb 24
10-K
2023 FY
Annual report
26 Feb 24
8-K
Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results
15 Feb 24
Transcripts
SWAV
Earnings call transcript
2023 Q4
15 Feb 24
SWAV
Earnings call transcript
2023 Q3
6 Nov 23
SWAV
Earnings call transcript
2023 Q2
7 Aug 23
SWAV
Earnings call transcript
2023 Q1
8 May 23
SWAV
Earnings call transcript
2022 Q4
16 Feb 23
SWAV
Earnings call transcript
2022 Q3
8 Nov 22
SWAV
Earnings call transcript
2022 Q2
9 Aug 22
SWAV
Earnings call transcript
2022 Q1
10 May 22
SWAV
Earnings call transcript
2021 Q4
18 Feb 22
SWAV
Earnings call transcript
2021 Q3
9 Nov 21
Latest ownership filings
4
LAURA FRANCIS
27 Mar 24
4
Isaac Zacharias
27 Mar 24
144
Notice of proposed sale of securities
26 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
4
Isaac Zacharias
12 Mar 24
4
FRANK T WATKINS
7 Mar 24
4
Trinh Phung
6 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
4
Isaac Zacharias
27 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Mar 24 | Zacharias Isaac | Common Stock | Sell | Dispose S | No | Yes | 287.67 | 4,000 | 1.15 mm | 56,818 |
26 Mar 24 | Francis Laura | Common Stock | Sell | Dispose S | Yes | Yes | 300 | 1,500 | 450.00 k | 3,551 |
26 Mar 24 | Francis Laura | Common Stock | Gift | Acquire G | Yes | No | 0 | 1,500 | 0.00 | 5,051 |
26 Mar 24 | Francis Laura | Common Stock | Gift | Dispose G | No | No | 0 | 1,500 | 0.00 | 1,233 |
26 Mar 24 | Francis Laura | Common Stock | Option exercise | Acquire M | No | Yes | 6.588 | 1,500 | 9.88 k | 2,733 |
26 Mar 24 | Francis Laura | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 6.588 | 1,500 | 9.88 k | 13,690 |
11 Mar 24 | Zacharias Isaac | Common Stock | Payment of exercise | Dispose F | No | No | 250.24 | 554 | 138.63 k | 60,818 |
6 Mar 24 | Watkins Frank T | Common Stock | Sell | Dispose S | No | Yes | 254.57 | 700 | 178.20 k | 4,532 |
6 Mar 24 | Watkins Frank T | Common Stock | Sell | Dispose S | No | Yes | 253.15 | 1,300 | 329.10 k | 5,232 |
6 Mar 24 | Watkins Frank T | Common Stock | Option exercise | Acquire M | No | Yes | 3.416 | 2,000 | 6.83 k | 6,532 |
News
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
16 Apr 24
5 Things To Know In Investing This Week - The Shockwave Takeover Issue
11 Apr 24
Shockwave Medical Demonstrates Consistent, Results In 'Real-World' Study; Investigators Presented 6-Month Data From The Full Population Of The REDUCER-I Study, Alongside Interim Long-Term Follow-Up Results To 3-Years
8 Apr 24
CL King Downgrades Shockwave Medical to Neutral
8 Apr 24
Leerink Partners Downgrades Shockwave Medical to Market Perform, Lowers Price Target to $335
8 Apr 24
Press releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, SWAV, MODN
23 Apr 24
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WIRE, ABIO, SWAV, MODN
22 Apr 24
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, SWAV, AIRC, MODN
16 Apr 24
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, ABIO, MODN
15 Apr 24
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HRT, ADTH, SWAV, AIRC
11 Apr 24